Institutional investors purchased a net $3.5 million shares of BTX during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 47.97% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADWOOD CAPITAL, INC. Bought 2.2 Million shares of BioTime Inc
BLACKROCK FUND ADVISORS Bought 360.2 Thousand shares of BioTime Inc
MORGAN STANLEY & CO. LLC Bought 188.2 Thousand shares of BioTime Inc